Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood with a propensity to metastasize. Current treatment for patients RMS includes conventional systemic chemotherapy, radiation therapy, and surgical resection; nevertheless, little no improvement in long term survival has been achieved decades—underlining need target discovery new therapeutic approaches targeting tumor cell...